Access cutting-edge melanoma treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access melanoma specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
The purpose of this study is to test whether the combination of fianlimab, cemiplimab, and ipilimumab is a safe and effective treatment that causes few or mild side effects for locally advanced or metastatic, unresectable, refractory melanoma.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this melanoma clinical trial in Commack, NY
If you're searching for melanoma treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.